Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
International Journal of Legal Medicine|March 5, 2004
Ninhydrin treatment as a screening method for the suitability of swabs taken from contact stains for DNA analysisK Anslinger, U Selbertinger, B Bayer, et al.Archives of Pathology & Laboratory Medicine|March 20, 2002
Pathologists in a teaching institution assess the value of the autopsyIlene B Bayer-Garner, Louis M Fink, Laura W LampsClinical and Experimental Immunology|November 14, 1997
Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulationJ C Hoffmann, C Herklotz, H Zeidler, et al.Bioprocess and Biosystems Engineering|September 22, 2019
The shortcomings of accurate rate estimations in cultivation processes and a solution for precise and robust process modelingB Bayer, B Sissolak, M Duerkop, et al.Cell Biology International|November 26, 1998
Human b cell differentiation: dependence on interactions with monocytes and T lymphocytes via CD40, CD80 (B7.1), and the CD2-Ligands CD48 and CD58 (LFA-3)J C Hoffmann, H Krüger, S Zielen, et al.Advances in Nutrition (Bethesda, Md.)|March 10, 2022
Habitual Green Kiwifruit Consumption Is Associated with a Reduction in Upper Gastrointestinal Symptoms: A Systematic Scoping ReviewSimone B Bayer, Chris M Frampton, Richard B Gearry, et al.Clinical Medicine & Research|June 3, 2005
The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevusIlene B Bayer-Garner, Doina Ivan, Mary R Schwartz, et al.Archives of Pathology & Laboratory Medicine|November 25, 2003
CD117, but not lysozyme, is positive in cutaneous plasmacytomaIlene B Bayer-Garner, Mary R Schwartz, Pei Lin, et al.Journal of Cutaneous Pathology|January 22, 2003
Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytomaIlene B Bayer-Garner, Lija Joseph, Ralph D Sanderson, et al.Scientific Reports|October 31, 2018
Brain Sensitivity to Exclusion is Associated with Core Network ClosureJoseph B Bayer, Matthew Brook O'Donnell, Christopher N Cascio, et al.Pageof 8